Great experience to be a part of this work, now need more work in incorporating longitudinal #PROs into clinical workflow and associating with novel biomarkers like #ctDNA.
So appreciate the amazing mentorship of @aparna1024 and @RyanNipp!!
@BrighamRadOnc @MGHCancerCenter
Proud of our team https://t.co/8F70FRODdt
Esp co 1st authors @jxj1998 (now in med school) @ASarafMD2 (new attending) for their incredible work. Started as 2017 office conversation w/ @RyanNipp when we said let’s do this. pros matter! ctDNA data coming next @MGHCancerCenter
Proud of our team https://t.co/8F70FRODdt
Esp co 1st authors @jxj1998 (now in med school) @ASarafMD2 (new attending) for their incredible work. Started as 2017 office conversation w/ @RyanNipp when we said let’s do this. pros matter! ctDNA data coming next @MGHCancerCenter
We really need to start incorporating PROs into routine oncology practice, but no easy way to do this in our EMR still. This is like geriatric assessment - needs institutional champions to move it forward, guidelines not enough. Difficult to find support.
This is an important paper, reinforcing yet again why PROs are not just an add-on, might be better than tumour markers! Patient-Reported Outcomes, Tumor Markers, and Survival Outcomes in Advanced GI Cancer https://t.co/oFx0iJt8W3
🪑Congratulations to @harvardmed Professor Andrea Ng MD, inaugural incumbent of the @BrighamWomens Distinguished Chair in Clinical Radiation Oncology! We are thrilled to celebrate her outstanding contributions to our field, institutions, and dept over the course of her career! 🏆
🗞️ Our latest work out today in @NatureComms
🌟 Led by star research fellow Anna Zapaishchykova
🧠 Automated temporalis muscle quantification and growth charts for children through adulthood https://t.co/ZtBKn89Dkh
🧵 1/
🚨Interested in learning how to provide high-quality, guideline-driven care to older adult pts w/cancer?
📢Tune in for a joint session w/@CARG to learn about @ASCO’s new Practical GA.
➡️ 10/17/23 @ 2pm EST
➡️Leave❓for the experts below
➡️Sign-up at https://t.co/7gLtJPfE0f
Fantastic turnout for our inaugural @ASTRO_org#EarlyCareer Committee session on Developing as an Early Career practitoner! It's been such a rewarding year with PIC Vice Chair @bananaP08 and major props to @JamesBatesMD for leading this session! #ASTRO23
Wonderful talk by @ASarafMD2 at the inaugural Early Career Professional Development session at #ASTRO23 with many great insights about key differences in mentorship, sponsorship, and benefits/challenges for early career Radiation Oncologists. Knocked it out of the park!! 💪🙌👏
How did the change in NCCN guidelines for testicular seminoma in 2012 impact outcomes? Check out our findings in the Red Journal https://t.co/Ka8nmyK0Bf @IJROBP from @harvardradonc, led by @danielbrosen and senior author @sophia_kamran @MGHCancerCenter [1/15]
1 of the first Qs I had at the start of my radonc journey on @BenjaminKannMD's service was how worried should I be abt pneumonitis when treating patients on osimertinib? 2yrs later & w/ lots of help from an amazing BWH/DFCI/MGH team, I am excited to share: https://t.co/FEzeVXLT7A
🚀 your body composition research with age- and sex-adjusted reference values for skeletal muscle cross-sectional area, density, gauge, SMI on Chest and Abdomen CT of the Framingham Heart Study 🫀https://t.co/v9aKb5jWHi Free online Z-score calculator, including batch processing!!